§ 40.85 - What are the cutoff concentrations for urine drug tests?  


Latest version.
  • § 40.85 What drugs do laboratories test for?

    are the cutoff concentrations for urine drug tests?

    (a) As a laboratory, you must

    test for the following five drugs or classes of drugs in a DOT drug test. You must not test “DOT specimens” for any other drugs.

    (a) Marijuana metabolites.

    (b) Cocaine metabolites.

    (c) Amphetamines.

    (d) Opioids.

    (e) Phencyclidine (PCP).

    [

    use the cutoff concentrations displayed in the following table for initial and confirmatory drug tests. All cutoff concentrations are expressed in nanograms per milliliter (ng/mL). The table follows:

    Initial test analyte Initial test cutoff1 Confirmatory test analyte Confirmatory test cutoff concentration
    Marijuana metabolites (THCA)2 50 ng/mL3 THCA15 ng/mL.
    Cocaine metabolite (Benzoylecgonine)150 ng/mL3 Benzoylecgonine100 ng/mL.
    Codeine/
    Morphine
    2000 ng/mLCodeine
    Morphine
    2000 ng/mL.
    2000 ng/mL.
    Hydrocodone/
    Hydromorphone
    300 ng/mLHydrocodone
    Hydromorphone
    100 ng/mL.
    100 ng/mL.
    Oxycodone/
    Oxymorphone
    100 ng/mLOxycodone
    Oxymorphone
    100 ng/mL.
    100 ng/mL.
    6-Acetylmorphine10 ng/mL6-Acetylmorphine10 ng/mL.
    Phencyclidine25 ng/mLPhencyclidine25 ng/mL.
    Amphetamine/
    Methamphetamine
    500 ng/mLAmphetamine
    Methamphetamine
    250 ng/mL.
    250 ng/mL.
    MDMA4/MDA5 500 ng/mLMDMA
    MDA
    250 ng/mL.
    250 ng/mL.

    (b) On an initial drug test, you must report a result below the cutoff concentration as negative. If the result is at or above the cutoff concentration, you must conduct a confirmation test.

    (c) On a confirmation drug test, you must report a result below the cutoff concentration as negative and a result at or above the cutoff concentration as confirmed positive.

    (d) You must report quantitative values for morphine or codeine at 15,000 ng/mL or above.

    [65 FR 79526, Dec. 19, 2000, as amended at 75 FR 49862, Aug. 16, 2010; 77 FR 26473, May 4, 2012; 82 FR 52244, Nov. 13, 2017. Redesignated and amended at 88 FR 27643, May 2, 2023]